North American Cannabis Holdings Inc (USMJ)

[Chartmaster]

PAOG Expects To Add CBD Nutraceuticals Revenue This Year

https://www.otcmarkets.com/stock/USMJ/news/PAOG-Expects-To-Add-CBD-Nutraceuticals-Revenue-This-Year?id=290531

PR Newswire

SANDUSKY, Ohio, Feb. 18, 2021

SANDUSKY, Ohio, Feb. 18, 2021 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today highlighted the company's anticipated revenue expected this year from its CBD nutraceutical expansion. Earlier this week, the company published an online, multimedia presentation detailing the company's CBD nutraceutical development expansion plans. The presentation includes details on PAOG's strategic engagements with Puration, Inc. (USOTC: PURA), North American Cannabis Holdings, Inc. (USOTC: USMJ) and Alkme Holdings, Inc. (USOTC: ALKM).

Follow the links below to view the presentation as a Flipbook:
PAOG Nutraceutical Development Expansion 2021

Or as a video:
PAOG Nutraceutical Development Expansion 2021

Learn more about PAOG at www.paogroupinc.com.

Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.

CONTACT INFORMATION

Contact Us:
Jim DiPrima
888-272-6472
[e-mail]

View original content:http://www.prnewswire.com/news-releases/paog-expects-to-add-cbd-nutraceuticals-revenue-this-year-301231106.html

SOURCE PAO Group, Inc.


PURA and USMJ Enter Strategic Negotiations

https://finance.yahoo.com/news/pura-usmj-enter-strategic-negotiations-173300687.html

Dallas, Texas--(Newsfile Corp. - January 29, 2021) - Puration, Inc. (OTC Pink: PURA) and North American Cannabis Holdings, Inc. (OTC Pink: USMJ) today announced entering strategic negotiations.

PURA produces EVERx CBD Sports Water with over $2 million in annual sales.

USMJ runs a cannabis ecommerce business that includes a cannabis products logistics operation.

PURA recently launched a hemp lifestyle business initiative built around a $1.3 million property purchase in Farmersville, Texas where the company plans to construct multiple hemp centric enterprises to promote the full industrial potential of hemp. Toward this end, PURA has already established partnerships with Alkame Holdings, Inc. (OTC Pink: ALKM) and PAO Group, Inc. (OTC Pink: PAOG).

USMJ has similarly initiated efforts to refresh the company business plan after the impact to the company's cannabis themed restaurant operations from the COVID-19 pandemic.

Today, PURA and USMJ make their co-development plans public for the first time. The two companies already share the same majority shareholder, and now plan to construct a strategic and synergistic strategy designed to optimize shareholder value for both companies within the evolving cannabis economic sector.

For more information on Puration, visit http://www.purationinc.com.

For more information on North American Cannabis Holdings, visit www.USMJ.com and www.GrowUSMJ.com.

Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company's current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company's contracts, the Company's liquidity position, the Company's ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Contact:
Puration, Inc.
Brian Shibley,
[e-mail]
[phone]

Steven Rash
CEO North American Cannabis Holdings, Inc.
[e-mail]
[phone]

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/73185

Filings 11/15/20 going current!!!
Lots of USMJ News:
https://www.otcmarkets.com/stock/USMJ/news
Filings 11/15/20:
https://www.otcmarkets.com/stock/USMJ/disclosure